Evaluating daily living activities in children with Juvenile Idiopathic Arthritis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study assesses the reliability and validity of the Glittre Activities of Daily Living Test specifically for children and adolescents diagnosed with Juvenile Idiopathic Arthritis (JIA). It aims to understand how chronic inflammation impacts their daily activities and overall well-being. By involving multidisciplinary health professionals, the study seeks to identify factors that limit these activities and improve the quality of life for affected individuals. Participants will be children aged 8-18 who have been diagnosed with JIA, and their experiences will be evaluated through structured assessments.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Being diagnosed with Juvenile Idiopathic Arthritis (JIA) according to The International League of Associations for Rheumatology (ILAR) classification
* Being between the ages of 8-18
* Volunteering to participate in research

Exclusion Criteria:

* Advanced heart/lung/liver/kidney disease, neurological disease and malignancies
* Having undergone major orthopedic surgery
* Not volunteering to participate in the study

Where it's running

• Hacettepe University Faculty of Physical Therapy and Rehabilitation
  Ankara, Turkey (Türkiye) Recruiting
• Hacettepe University Faculty of Physical Therapy and Rehabilitation
  Ankara, Turkey (Türkiye) Not yet recruiting

Study contacts

• Principal investigator: Sinan Buran, MSc — Hacettepe University Faculty of Physical Therapy and Rehabilitation
• Study coordinator: Sinan Buran, MSc
• Email: pt.sinanburan@gmail.com
• Phone: +905076393104

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Predicting the course of early-onset juvenile idiopathic arthritis using a multidimensional model

  Researchers are testing a comprehensive model to predict how early-onset JIA will progress in affected children and how a small control group with iridocyclitis compares.

  Recruiting at 2 sites Istituto Giannina Gaslini · Genova and 1 other locations · NCT07882667

• Understanding subtypes of chronic musculoskeletal pain in youth

  This observational study tests whether distinct brain and immune profiles can explain chronic musculoskeletal pain in teens and young adults to guide more precise treatments.

  Recruiting Children's Hospital Medical Center, Cincinnati · Cincinnati, Ohio · NCT07602595

• Open-label extension with filgotinib for juvenile idiopathic arthritis

  This long-term open-label extension sees if filgotinib stays safe and continues to control symptoms in children aged 8–17 with polyarticular or systemic juvenile idiopathic arthritis who benefited from earlier treatment.

  Recruiting at 2 sites Phase 3 Alfasigma S.p.A. · Le Kremlin-Bicêtre and 3 other locations · NCT07553182

• Structured or video-game–based core stabilization for children with juvenile idiopathic arthritis

  This study will try whether a regular structured core exercise program or a fun exergaming-based core program helps children aged 8–13 with juvenile idiopathic arthritis improve strength, reduce pain, and move better.

  Recruiting Istanbul University - Cerrahpasa · Istanbul, Buyukcekmece · NCT07234747

• Tofacitinib in Juvenile Idiopathic Arthritis

  This study looks at real-world use of tofacitinib to see if it helps control Juvenile Idiopathic Arthritis in kids over about 12 months.

  Recruiting at 7 sites Consorci Sanitari de l'Alt Penedès i Garraf · A Coruña, A Coruña and 6 other locations · NCT07211932

• Parents' pain catastrophizing in children with juvenile idiopathic arthritis

  See if parents' worrying and negative thoughts about their child's pain are linked to treatment adherence and biopsychosocial outcomes in children with juvenile idiopathic arthritis.

  Recruiting Hacettepe University · Çankaya, Ankara · NCT07185750

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.